For CD, Omvoh 300 mg via 2 injections (1 injection of 100 mg and 1 injection of 200 mg administered in any order). See the Prescribing Information for dosage and administration instructions, and refer to the Instructions for Use included with the devices. CD=Crohn's disease; IV=intravenous; UC=ulcerative colitis. Omvoh. Prescribing Information.

May 17, 2024 · The recommended induction dosage of OMVOH is 300 mg administered by intravenous infusion over at least 30 minutes at Week 0, Week 4, and Week 8. The recommended maintenance dosage of OMVOH is 200 mg administered by subcutaneous injection (given as two consecutive injections of 100 mg each) at Week 12, and every 4 weeks thereafter.

See the Omvoh Prescribing Information for more detailed dosage and administration instructions. Dose for Ulcerative Colitis: Week 0, 4, and 8: Omvoh 300 mg IV over at least 30 minutes.

You will receive your first 3 doses of Omvoh through a vein in your arm (intravenous infusion) in a healthcare facility by a healthcare provider every 4 weeks. Each infusion will last about 30 minutes (for ulcerative colitis) or about 90 minutes (for Crohn’s disease).

administration of Omvoh for IV i. tration, whenever solution and container permit. The solution should be a clear to opalescent, colorless to slightly yellow to slight. y brown solution, and free of visible particles. Do not use Omvo. ium chloride injection or 5%

consecutive injections of 100 mg and 200 mg in any order) [see Dosage and Administration (2.5) and How Supplied/Storage and Handling. coloration prior to administration, whenever solution and container permit. The solution should be a clear to opalescent, colorless to slightly yellow to slightly brown solution, and free of visible particles. Do .

The recommended induction dosage of OMVOH is 300 mg administered by intravenous infusion over at least 30 minutes at Week 0, Week 4, and Week 8 [see Dosage and Administration (2.3)].

Jan 22, 2025 · The recommended induction dosage of Omvoh is 300 mg administered by intravenous infusion over at least 30 minutes at Weeks 0, 4, and 8. The recommended maintenance dosage of Omvoh is 200 mg administered by subcutaneous injection (given as two consecutive injections of 100 mg each) at Week 12, and every 4 weeks thereafter.

sing. If patients do not have adequate therapeutic response at Week 12 after induction dosing, consider extended induction dosing by administering 300 mg Omvoh by intravenous infusion at Weeks 12, 16, and 2.

Jan 22, 2025 · OMVOH is indicated for the treatment of: moderately to severely active ulcerative colitis in adults. moderately to severely active Crohn's disease in adults.